13F Holdings
中文EN

LEEEF Leef Brands Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1711141 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin42.1%
Operating margin-16.3%
Net margin-38.2%
FCF margin-23.4%
EBITDA margin-12.3%

Returns

ROE—
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets92.5%
Debt / equity0.00x
Current ratio2.24x
Interest coverage-3.95x

Cash quality & payout

Operating cash flow / net income0.40x
Accruals ratio—
Payout ratio—
Capex / revenue8.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$34.79M$28.50M
Cost of revenue$24.30M$20.81M
Gross profit$10.48M$7.68M
R&D expense$19,696$18,983
SG&A expense$3.12M$2.40M
Operating income-$7.59M-$7.99M
Interest expense$2.37M$5.16M
Pretax income-$15.11M-$21.31M
Income tax$2.52M$3.31M
Net income-$17.63M-$24.62M
EBITDA-$6.33M-$6.94M
EPS (basic)-0.10-0.17
EPS (diluted)-0.10-0.17
Weighted avg. shares (diluted)184.91M142.60M
Balance sheet
Cash & equivalents$2.19M$2.73M
Receivables$1.59M$2.39M
Inventory$3.35M$4.22M
Current assets$8.15M$10.48M
PP&E, net$25.04M$26.04M
Goodwill$0$0
Intangibles$1.12M$2.23M
Total assets$36.40M$42.98M
Current liabilities$8.35M$11.41M
Total liabilities$44.67M$55.41M
Shareholders' equity-$8.27M-$12.43M
Shares outstanding257.95M172.98M
Cash flow statement
Operating cash flow-$336,895-$1.05M
Capital expenditure$642,014$5.92M
Free cash flow-$978,909-$6.97M
Investing cash flow-$749,223-$6.27M
Financing cash flow$545,204$3.63M
Depreciation & amortization$1.26M$1.04M
Stock-based compensation$2.69M$1.30M

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.